The NBA has created a new private equity division primarily focused on early-stage funding rounds in equipment, media, fan engagement, betting, and fantasy sports.
The division could also look to invest in later-stage deals if there is a strategic alignment.
The NBA is moving away from passive, opportunistic investments in favor of a more formal operation that will boost the value of its portfolio and identify innovations to improve basketball.
The NBA has nearly 20 companies in its portfolio, including investments in major firms like data provider Sportradar, blockchain fantasy game specialist Sorare and apparel firm New Era.,with stakes totaling US$1 billion.
The 2022 intake focused on ankle injury innovation, elite youth player performance, referee training and development, and youth health and wellness.


India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
What makes a good football coach? The reality behind the myths
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
From Messi to Mika Häkkinen: how top athletes can slow down time
How did sport become so popular? The ancient history of a modern obsession
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Apple Eyes U.S. Formula 1 Broadcast Rights in Major Sports Streaming Push
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



